Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats

Peer Review reports

Original Submission
4 Jan 2013	Submitted	Original manuscript
23 Jan 2013	Reviewed	Reviewer Report - Vincent Poitout
25 Jan 2013	Reviewed	Reviewer Report - Dave Smith
1 Apr 2013	Author responded	Author comments - B P SOMESH
Resubmission - Version 2
1 Apr 2013	Submitted	Manuscript version 2
22 Apr 2013	Reviewed	Reviewer Report - Vincent Poitout
26 Apr 2013	Reviewed	Reviewer Report - Dave Smith
6 May 2013	Author responded	Author comments - B P SOMESH
Resubmission - Version 3
6 May 2013	Submitted	Manuscript version 3
Publishing
15 May 2013	Editorially accepted
21 May 2013	Article published	10.1186/2050-6511-14-28

Back to article page